The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus

Kraaij, T.; Kamerling, S.W.A.; Rooij, E.N.M. de; Daele, P.L.A. van; Bredewold, O.W.; Bakker, J.A.; ... ; Teng, Y.K.O. (2018)

Article / Letter to editor

• Systemic lupus erythematosus
• Lupus nephritis
• Refractory lupus
• Rituximab
• Belimumab
• Neutrophil extracellular traps
• Autoantibody
• Clinical trial

• All authors: Kraaij, T.; Kamerling, S.W.A.; Rooij, E.N.M. de; Daele, P.L.A. van; Bredewold, O.W.; Bakker, J.A.; Bajema, I.M.; Scherer, H.U.; Toes, R.E.M.; Huizinga, T.J.W.; Rabelink, T.J.; Kooten, C. van; Teng, Y.K.O.
• Date: 2018-07-31
• Journal: Journal of Autoimmunity
• Volume: 91
• Pages: 45 - 54
• DOI: doi:10.1016/j.jaut.2018.03.003